• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cystatin C to predict renal disease and cardiovascular risk.

作者信息

Lees Jennifer S, Mark Patrick B

机构信息

Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

Glasgow Renal and Transplant Unit, NHS Greater Glasgow and Clyde, Glasgow, UK.

出版信息

Nephrol Dial Transplant. 2021 Jan 1;36(1):39-41. doi: 10.1093/ndt/gfaa152.

DOI:10.1093/ndt/gfaa152
PMID:32514520
Abstract
摘要

相似文献

1
Cystatin C to predict renal disease and cardiovascular risk.胱抑素C用于预测肾脏疾病和心血管风险。
Nephrol Dial Transplant. 2021 Jan 1;36(1):39-41. doi: 10.1093/ndt/gfaa152.
2
Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis.血清胱抑素 C 作为透析起始时终末期肾病患者心血管事件的预测因子。
Clin Exp Nephrol. 2012 Jun;16(3):456-63. doi: 10.1007/s10157-011-0583-1. Epub 2012 Jan 26.
3
Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function.血清胱抑素 C 升高是肾功能相对正常人群心血管事件的独立预测因子。
J Nephrol. 2012 May-Jun;25(3):426-30. doi: 10.5301/jn.5000020.
4
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.循环胱抑素 C 是稳定型冠心病患者心血管结局、肾功能损害和长期死亡率的独立风险标志物：脂质研究。
J Am Heart Assoc. 2022 Mar;11(5):e020745. doi: 10.1161/JAHA.121.020745. Epub 2022 Feb 18.
5
Does Cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?胱抑素 C 在腹膜透析中除了与残余肾功能相关外，是否还能作为代谢替代物发挥作用？
J Bras Nefrol. 2020 Mar;42(1):31-37. doi: 10.1590/2175-8239-JBN-2019-0007. Epub 2019 Dec 2.
6
High Prevalence of Vitamin D Deficiency and Correlation with Cystatin-C and Other Cardiovascular and Renal Risk Biomarkers in Patients with Type 2 Diabetes Mellitus Complicated with Hypertension.2 型糖尿病合并高血压患者维生素 D 缺乏的高患病率及其与胱抑素 C 及其他心血管和肾脏风险生物标志物的相关性。
Curr Diabetes Rev. 2021;17(1):81-90. doi: 10.2174/1573399816666200516174352.
7
How to understand the association between cystatin C levels and cardiovascular disease: Imbalance, counterbalance, or consequence?如何理解半胱氨酸蛋白酶抑制剂 C 水平与心血管疾病之间的关联：失衡、平衡还是后果？
J Cardiol. 2013 Dec;62(6):331-5. doi: 10.1016/j.jjcc.2013.05.015. Epub 2013 Jul 9.
8
Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease.胱抑素C：无慢性肾脏病患者心肌梗死后的一种预后标志物。
J Saudi Heart Assoc. 2016 Jul;28(3):144-51. doi: 10.1016/j.jsha.2015.10.001. Epub 2015 Oct 9.
9
Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.胱抑素 C 与接受冠状动脉造影术的个体的全因和心血管死亡率独立相关。路德维希港风险和心血管健康（LURIC）研究。
Atherosclerosis. 2013 Aug;229(2):541-8. doi: 10.1016/j.atherosclerosis.2013.04.027. Epub 2013 May 3.
10
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.胱抑素C与无慢性肾脏病老年人的心血管及肾脏预后
Ann Intern Med. 2006 Aug 15;145(4):237-46. doi: 10.7326/0003-4819-145-4-200608150-00003.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.肝肾综合征-急性肾损伤的美国现行管理及特利加压素的潜力
Liver Transpl. 2021 Aug;27(8):1191-1202. doi: 10.1002/lt.26072. Epub 2021 Jul 14.